60 related articles for article (PubMed ID: 29035843)
1. Generation of a human control PBMC derived iPS cell line TUSMi001-A from a healthy male donor of Han Chinese genetic background.
Wang Y; Zhang Y; Zhang J; Lu J; Yang C; Zhao J; Li G; Liu Z; Lei Y
Stem Cell Res; 2017 Dec; 25():22-25. PubMed ID: 29035843
[TBL] [Abstract][Full Text] [Related]
2. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B Virus x Protein Increases Cellular OCT3/4 and MYC and Facilitates Cellular Reprogramming.
Sanal MG; Gupta S; Saha R; Vats N; Sarin SK
Cell Reprogram; 2023 Oct; 25(5):224-237. PubMed ID: 37769039
[TBL] [Abstract][Full Text] [Related]
4. Simple generation of human induced pluripotent stem cells using poly-beta-amino esters as the non-viral gene delivery system.
Montserrat N; Garreta E; González F; Gutiérrez J; Eguizábal C; Ramos V; Borrós S; Izpisua Belmonte JC
J Biol Chem; 2011 Apr; 286(14):12417-28. PubMed ID: 21285354
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of Fibroblasts to Human iPSCs by CRISPR Activators.
Weltner J; Trokovic R
Methods Mol Biol; 2021; 2239():175-198. PubMed ID: 33226620
[TBL] [Abstract][Full Text] [Related]
6. Establishment of an induced pluripotent stem cell line (SDCHi001-A) from a healthy Chinese child donor.
Wang L; Zeng Q; Wang S; Wu D; Wang J; Zhang H; Lv X
Stem Cell Res; 2024 Feb; 74():103278. PubMed ID: 38118205
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cell line, NIMHi009-A, from PBMCs of an adult healthy male.
Arunachal G; Milind Nimonkar M; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
Stem Cell Res; 2024 Apr; 76():103349. PubMed ID: 38368738
[TBL] [Abstract][Full Text] [Related]
8. Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease.
Baek D; Lee KG; Sohn HY; Park JH; Lee HK; Bayarsaikhan G; Yoo SW; Lee B; Kim JS; Koh YH; Kwon M
Stem Cell Res; 2024 Apr; 76():103358. PubMed ID: 38447455
[TBL] [Abstract][Full Text] [Related]
9. Human induced pluripotent stem cell line from fibroblasts (HEBHMUi015-A) and chondrogenic differentiation.
Zhang Y; Liu Y; Yan W; Zhang X; Hou Y; Zhou Z; Guo R; Liu G; Ma J
Stem Cell Res; 2023 Oct; 72():103201. PubMed ID: 37856927
[TBL] [Abstract][Full Text] [Related]
10. Highly cooperative chimeric super-SOX induces naive pluripotency across species.
MacCarthy CM; Wu G; Malik V; Menuchin-Lasowski Y; Velychko T; Keshet G; Fan R; Bedzhov I; Church GM; Jauch R; Cojocaru V; Schöler HR; Velychko S
Cell Stem Cell; 2024 Jan; 31(1):127-147.e9. PubMed ID: 38141611
[TBL] [Abstract][Full Text] [Related]
11. An achievement has been made in establishing an induced pluripotent stem cell line (SDPHi005-A) from a healthy Chinese male donor.
Shao J; Jin Y; Shao C; Zhang X; Yang G
Stem Cell Res; 2024 Mar; 77():103393. PubMed ID: 38531229
[TBL] [Abstract][Full Text] [Related]
12. Expression and Functional Analysis of core stemness factors OSKM (OCT4, SOX2, KLF4, and MYC) in Pan-cancer.
Hong L; Hong S; Zhang X
Medicine (Baltimore); 2023 Dec; 102(48):e36433. PubMed ID: 38050242
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of the iPS cell line (SYSUSHi001-A) derived from the peripheral blood mononuclear cells (PBMCs) of a 33-year-old patient with acute myeloid leukemia (AML).
Yuan L; Xie M; Tao Y; Chen X; Xu X; Wang X
Stem Cell Res; 2024 Feb; 77():103360. PubMed ID: 38608356
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a transgene-free iPS cell line (SDCHi003-A) from a young patient bearing a NPRL2 mutation and suffering from Epilepsy.
Su S; Zhao F; Zhang H; Liu Y; Li Z; Zhang H; Wang Y; Fang F; Liu Y
Stem Cell Res; 2024 Apr; 76():103366. PubMed ID: 38430737
[TBL] [Abstract][Full Text] [Related]
15. Generation of two induced pluripotent stem cell lines from healthy patients of African American ancestry.
Mullen M; Kojic A; Alamana C; Canel G; Lai C; Knowles JW; Wu JC
Stem Cell Res; 2024 Apr; 76():103322. PubMed ID: 38359472
[TBL] [Abstract][Full Text] [Related]
16. Generation of integration-free human induced pluripotent stem cells from a patient with sporadic Parkinson's disease.
Lee Y; Jeong D; Ham S; Son J; Ko K
Stem Cell Res; 2024 Apr; 77():103416. PubMed ID: 38615589
[TBL] [Abstract][Full Text] [Related]
17. Generation of a control induced pluripotent stem cell line (SDUCHi001-A) from a healthy male donor.
Li C; Zhang F; Wang X; Chen M
Stem Cell Res; 2024 Apr; 77():103433. PubMed ID: 38718593
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human induced pluripotent stem cell (iPSC) SZGJMSi004-A line from a 28-year-old Han male patient with depression.
Yin X; Cai Y; Jia N; Hui L; Zhu Z
Stem Cell Res; 2024 Apr; 77():103428. PubMed ID: 38696853
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line (SHETi004-A) from a Chinese Han child with left bundle branch block.
Wang T; Hou S; Chen J; Zhao X; Xiao T; Hou C; Zhou C
Stem Cell Res; 2023 Dec; 73():103227. PubMed ID: 37931536
[TBL] [Abstract][Full Text] [Related]
20.
Chuang HM; Huang MH; Chen YS; Harn HJ
Cell Transplant; 2020; 29():963689720907565. PubMed ID: 32233795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
